Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Uprosertib is a selective, orally bioavailable inhibitor of Akt (IC50s = 180, 328, and 38 nM for Akt1, Akt2, and Akt3, respectively).1 Uprosertib preferentially inhibits the proliferation of human cancer cell lines with Akt pathway activation via PI3K/PTEN mutation or loss.2 It can cause cell cycle arrest and consequent tumor growth inhibition in mice bearing either BT474 breast tumor or SKOV3 ovarian tumor xenografts.2
WARNING This product is not for human or veterinary use.
1. Characterization of a chemical affinity probe targeting Akt kinases. J. Proteome Res. 12(8), 3792-3800 (2013).
2. Discovery of novel AKT inhibitors with enhanced anti-